Across TCGA pan-cancer cohorts, OR10R1P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR10R1P data layer.
The strongest signal is observed in uterine carcinosarcoma (UCS), where higher OR10R1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR10R1P expression acts as an unfavorable survival marker, although some lineages such as THYM and GBM show a favorable association.
UCS, ACC, and LUSC are the cancer types where OR10R1P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.